Cancerwise

Top

MD Anderson’s blog features stories from survivors and caregivers, and our experts’ insights on cancer treatment, research breakthroughs, healthy living and more.

11 new research advances from the past year

BY Erin Dahlstrom, Ph.D.

December 19, 2024

Over the past year, MD Anderson researchers and clinicians have investigated the gut microbiome, examined the earliest genesis of lung...

Three people in white lab coats gather around a white board covered in scientific diagrams, watching a woman work on the white board in red dry erase marker

Microscope image of small cell lung cancer cells in shades of blue

Advances in small cell lung cancer classification

BY Erin Dahlstrom, Ph.D.

November 25, 2024

Most patients with lung cancer have non-small cell lung cancer. However, around 15% of patients have a less-common type called small...

Dr. Manning posing in front of an open hot box in the lab

What is theranostics?

BY Erin Dahlstrom, Ph.D.

October 21, 2024

You may have heard the term theranostics when reading about cancer treatments, but what does it mean? The word theranostics is a...

Innovative directions in immunotherapy research

BY Erin Dahlstrom, Ph.D.

September 11, 2024

Immunotherapy is a cancer treatment that uses a patient’s immune system to target their cancer cells. Some common types of...

Illustration of a DNA strand emerging from a set of lungs

How are targeted therapies used in lung cancer treatment?

BY Erin Dahlstrom, Ph.D.

July 30, 2024

Lung cancer is the third-most common type of cancer and the most common cause of cancer-related deaths in the United States, according...

Illustration of blood cells being produced in the bone marrow

What’s new in leukemia research?

BY Erin Dahlstrom, Ph.D.

May 29, 2024

Leukemia is an overarching term encompassing several subtypes of blood cancers. Blood cells are produced in the bone marrow, the...

Light blue double stranded DNA with red portion indicating damaged component on dark blue background

What are PARP inhibitors?

BY Erin Dahlstrom, Ph.D.

April 03, 2024

PARP inhibitors are a type of targeted therapy commonly used to treat breast cancer and ovarian cancer, among others. They target...

11 new research advances from the past year

Advances in small cell lung cancer classification

What is theranostics?

Share Your Story

Request an Appointment

Donate Blood

Innovative directions in immunotherapy research

How are targeted therapies used in lung cancer treatment?

What’s new in leukemia research?

What are PARP inhibitors?

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson